Brief: Talaris Therapeutics Announces Third Quarter 2021 Financial Results And Provides Business Update
12/11/2021 12:37
Nov 12 (Reuters) - Talaris Therapeutics Inc TALS.O :
* TALARIS THERAPEUTICS ANNOUNCES THIRD QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q3 LOSS PER SHARE $0.32
Source text for Eikon: ID:nGNX2nWYWY
Further company coverage: TALS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy